Home›Stock Screener›Hester Biosciences›Quarterly Results

Hester Biosciences Quarterly Results

Latest Quarter Net Profit
₹17 Cr
QMar 2026
Quarterly Results

Hester Biosciences quarterly results. In Mar 2026, Hester Biosciences (HESTERBIO) reported revenue ₹102 Cr and net profit ₹17 Cr — revenue +34.2% YoY. For annual financials, live price and key ratios, visit Hester Biosciences stock price NSE.

HESTERBIO Quarterly Results — Revenue, Profit & EPS Highlights

Hester Biosciences latest quarter revenue, net profit, EPS and QoQ/YoY growth rates. Review HESTERBIO price earnings ratio to evaluate earnings-based valuation against sector peers.

  • Revenue of ₹102 Cr in Mar 2026 (-38.6% vs Jun 2026, +34.2% vs Mar 2025)
  • Net Profit of ₹17 Cr in Mar 2026 (-82.5% vs Jun 2026, +750.0% vs Mar 2025)
  • EBITDA of ₹36 Cr in Mar 2026 (-67.9% vs Jun 2026)
  • Operating Margin of 34.0% in Mar 2026 (+5.0pp vs Jun 2026)
  • Earnings Per Share of ₹19.45 in Mar 2026 (-82.9% vs Jun 2026)

Hester Biosciences Quarterly Results — Revenue, EBITDA, Net Profit & EPS

HESTERBIO quarterly revenue, expenses, EBITDA, net profit, EPS and operating margin with QoQ and YoY comparison.

Metric Mar 2026 Jun 2026 Sept 2025 Mar 2025 Jun 2025 QoQ YoY
Revenue (₹ Cr) 102 166 83 76 88 -38.6% 34.2%
Net Profit (₹ Cr) 17 97 14 2 17 - -
EBITDA (₹ Cr) 36 112 24 14 26 - -
EPS (₹) 19.45 113.71 16.85 1.82 20.33 - -
Operating Margin (%) 34.0% 29.0% 17.0% 23.0% 27.0% - -

HESTERBIO Share Price Trend — 1-Year Movement Across Quarterly Results

Hester Biosciences 1-year share price in ₹ overlaid with quarterly earnings dates — NSE/BSE closing prices. Check Hester Biosciences market worth to track the company's total market size over time.

Profitability Ratios

Profit Margin 16.7%
EBITDA Margin 35.3%
Operating Margin 34.0%
ROE (Annual) 18.5%

Balance Sheet Highlights

Total Assets ₹678 Cr
Total Equity ₹368 Cr
Current Assets ₹209 Cr
Current Liabilities ₹158 Cr

Cash Flow Analysis

Operating Cash Flow ₹64 Cr
Investing Cash Flow ₹-18 Cr
Financing Cash Flow ₹-49 Cr
Net Cash Flow ₹-3 Cr

Current Market Data

Current Price ₹2105.50
Exchange NSE
Last Updated Oct 05, 2026

Revenue Trend (₹ Cr)

Mar 2025 76
Sept 2025 83
Jun 2026 166
Mar 2026 102

Net Profit Trend (₹ Cr)

Mar 2025 2
Sept 2025 14
Jun 2026 97
Mar 2026 17

Operating Margin Trend (%)

Mar 2025 23.0%
Sept 2025 17.0%
Jun 2026 29.0%
Mar 2026 34.0%

HESTERBIO vs Healthcare Peers — Quarterly Revenue, Profit & Market Cap

Hester Biosciences latest quarter revenue and net profit vs Healthcare competitors — market cap, price and earnings comparison.

Company Latest Quarter Market Cap (₹ Cr) Price (₹) Revenue (₹ Cr) Net Profit (₹ Cr) Rev QoQ % Rev YoY % Profit Margin % P/E Ratio
Sun Pharmaceutical
Mar 2026 		₹432,120.23 Cr 1779.7 15,018 2,710 -5.6% - 18.0% 157.5
Divis Laboratories
Mar 2026 		₹244,124.91 Cr 9196.0 2,986 751 -5.0% - 25.2% 324.8
Torrent Pharmaceuti…
Mar 2026 		₹188,719.51 Cr 4772.0 4,111 364 +27.7% +42.2% 8.9% 414.6
Zydus Life Science
Mar 2026 		₹113,615.69 Cr 1139.0 7,569 1,341 -4.3% - 17.7% 90.0
Laurus Labs
Mar 2026 		₹109,629.35 Cr 1971.4 1,823 282 -10.5% - 15.5% 381.3
Sector Quarterly Performance Comparison
Healthcare sector • Latest quarterly results
▲ Positive Growth
▼ Negative Growth
- No Data

QoQ: Quarter over Quarter • YoY: Year over Year
All amounts in ₹ Crores